PSTX — Poseida Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Poseida Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	125	309	206	282	212
Net Total Accounts Receivable
Net Total Receivables	—	—	—	9.09	9.01
Prepaid Expenses
Total Other Current Assets
Total Current Assets	127	314	214	299	226
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10.9	48.3	48.2	46.7	40.8
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	147	371	269	352	274
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	21.9	30	43.3	53.9	71.3
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	74.3	110	113	164	170
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	72.7	262	156	188	104
Total Liabilities & Shareholders' Equity	147	371	269	352	274
Total Common Shares Outstanding